Patrícia Maciejewski

Statistics

Publications

Citations

673

H-Index

Active since

1995

Affiliations

Gilead Sciences (United States)(Current)

Patrícia Maciejewski is an author at Gilead Sciences (United States) specializing in pharmacology, tyrosine kinase inhibitors, and tyrosine kinase inhibition.

ORCID

Publications per year

1995–2014

Publications

Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis

Julie A. Di Paolo, Tao Huang, Mercedesz Balázs et al. · Nature Chemical Biology · 2010 · 332 citations · Full text

Life Sciences, Immunology, Medicinal Chemistry +16

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Kevin Currie, Jeffrey E. Kropf, Tony Lee et al. · Journal of Medicinal Chemistry · 2014 · 171 citations · Full text

Medicine, Oncology, Pharmacology +13

Mutation of Serine 90 to Glutamic Acid Mimics Phosphorylation of Bovine Prolactin

Patrícia Maciejewski, Francis C. Peterson, Patricia J. Anderson et al. · Journal of Biological Chemistry · 1995 · 69 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +8

A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor

Russell T. Burke, Sarah Meadows, Marc Loriaux et al. · Oncotarget · 2014 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Imidazo[1,2-a]pyrazine diaryl ureas: Inhibitors of the receptor tyrosine kinase EphB4

Scott A. Mitchell, M. Diana Danca, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 5